Company intelligence / Profile preview

BioTrim

Ownership: Private
Development stage: Other

Overview

BioTrim was a biotechnology company focused on the development of therapeutic solutions for obesity and metabolic disorders. The company aimed to leverage small molecule interventions to address weight management and related health issues. Despite its initial focus on the high-demand metabolic health sector, the company is no longer active in the biotechnology space. Its historical efforts were centered on early-stage research and development within the weight loss therapeutic category.

Therapeutic areas: EndocrinologyMetabolic Disorders
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on BioTrim.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioTrim.

Explore the full profile